Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Horizon Pharma PLC (NASDAQ:HZNP)

12.27
Delayed Data
As of Sep 21
 +0.16 / +1.32%
Today’s Change
9.45
Today|||52-Week Range
21.98
-24.17%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Revenue and IncomeNet Revenues273.7M310.3M220.9M289.5M
 
 
 
 
 
Cost of Goods Sold26.3M82.4M67.6M58.6M
 
 
 
 
 
Depreciation And Amortization51.9M67.4M71.5M71.6M
 
 
 
 
 
 
Operating ExpensesGross Income195.4M160.6M81.7M159.4M
 
 
 
 
 
General Expenses144.7M224.7M177.5M341.0M
 
 
 
 
 
Research And Development12.9M24.0M13.1M162.8M
 
 
 
 
 
Total Operating Expenses222.9M374.5M316.6M471.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income50.8M-64.1M-95.8M-181.7M
 
 
 
 
 
Extraordinary Charge-72.1M-66.0M-10.1M-4.0M
 
 
 
 
 
Interest Expense On Debt19.1M28.9M32.0M31.6M
 
 
 
 
 
Other Expenses6.8M-881.0K-224.0K6.0M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-33.6M-159.8M-138.1M-211.3M
 
 
 
 
 
Income Taxes-27.7M-29.3M-47.6M-1.8M
 
 
 
 
 
Net Income-5.9M-130.5M-90.6M-209.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS161.0M161.4M162.0M162.9M
 
 
 
 
 
Shares To Calculate EPS Diluted161.0M161.4M162.0M162.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.04-$0.81-$0.56-$1.29
 
 
 
 
 
EPS Diluted-$0.04-$0.81-$0.56-$1.29